Tomáš Reischig

1.3k total citations
42 papers, 930 citations indexed

About

Tomáš Reischig is a scholar working on Epidemiology, Psychiatry and Mental health and Transplantation. According to data from OpenAlex, Tomáš Reischig has authored 42 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 13 papers in Psychiatry and Mental health and 12 papers in Transplantation. Recurrent topics in Tomáš Reischig's work include Cytomegalovirus and herpesvirus research (24 papers), Herpesvirus Infections and Treatments (16 papers) and Neurological Complications and Syndromes (13 papers). Tomáš Reischig is often cited by papers focused on Cytomegalovirus and herpesvirus research (24 papers), Herpesvirus Infections and Treatments (16 papers) and Neurological Complications and Syndromes (13 papers). Tomáš Reischig collaborates with scholars based in Czechia, United States and Croatia. Tomáš Reischig's co-authors include Pavel Jindra, Ondřej Hes, Vladislav Třeška, Mirko Bouda, Miroslava Švecová, K Opatrný, Stanislav Kormunda, Martin Kacer, Daniel Lysák and Lukáš Kielberger and has published in prestigious journals such as Journal of the American Society of Nephrology, Transplantation and American Journal of Transplantation.

In The Last Decade

Tomáš Reischig

42 papers receiving 921 citations

Peers

Tomáš Reischig
Raisa Loginov Finland
R. Méndez United States
David C. Lowance United States
Mark Harber United Kingdom
Marie‐Christine Moal France
Elizete Keitel Brazil
Ngoc Thai United States
Miguel S. West United States
Richard Rohrer United States
Jean-Pierre Venetz Switzerland
Raisa Loginov Finland
Tomáš Reischig
Citations per year, relative to Tomáš Reischig Tomáš Reischig (= 1×) peers Raisa Loginov

Countries citing papers authored by Tomáš Reischig

Since Specialization
Citations

This map shows the geographic impact of Tomáš Reischig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Reischig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Reischig more than expected).

Fields of papers citing papers by Tomáš Reischig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Reischig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Reischig. The network helps show where Tomáš Reischig may publish in the future.

Co-authorship network of co-authors of Tomáš Reischig

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Reischig. A scholar is included among the top collaborators of Tomáš Reischig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Reischig. Tomáš Reischig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reischig, Tomáš, Martin Kacer, Kristýna Pivovarčíková, et al.. (2023). A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients. Journal of the American Society of Nephrology. 34(5). 920–934. 12 indexed citations
2.
Kacer, Martin, et al.. (2023). Safety and efficacy of one and two booster doses of SARS‐CoV‐2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial. Transplant Infectious Disease. 25(5). e14150–e14150. 5 indexed citations
3.
Reischig, Tomáš, Martin Kacer, Lukáš Kielberger, et al.. (2021). Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. American Journal of Transplantation. 22(3). 801–812. 33 indexed citations
4.
5.
Reischig, Tomáš, Martin Kacer, Ondřej Hes, et al.. (2019). Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy. American Journal of Transplantation. 19(9). 2457–2467. 26 indexed citations
6.
Reischig, Tomáš, Martin Kacer, Ondřej Hes, et al.. (2019). Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies. Nephrology Dialysis Transplantation. 34(11). 1970–1978. 16 indexed citations
7.
Reischig, Tomáš, Martin Kacer, Petra Hrubá, et al.. (2018). Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial. BMC Infectious Diseases. 18(1). 573–573. 17 indexed citations
8.
Reischig, Tomáš, Martin Kacer, Pavel Jindra, et al.. (2014). Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation. Clinical Journal of the American Society of Nephrology. 10(2). 294–304. 31 indexed citations
9.
Kielberger, Lukáš, Mirko Bouda, Pavel Jindra, & Tomáš Reischig. (2012). Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients. Kidney & Blood Pressure Research. 35(6). 407–416. 15 indexed citations
10.
Reischig, Tomáš, Petra Hřibová, Pavel Jindra, et al.. (2012). Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation. Journal of the American Society of Nephrology. 23(9). 1588–1597. 56 indexed citations
11.
Reischig, Tomáš, et al.. (2010). Evaluation of Three Different Methods to Prevent Dialyzer Clotting Without Causing Systemic Anticoagulation Effect. Artificial Organs. 35(1). 83–88. 34 indexed citations
12.
13.
Kacerovská, Denisa, Radek Vrtěl, Michal Michal, et al.. (2009). TSC2/PKD1 Contiguous Gene Syndrome: A Report of 2 Cases With Emphasis on Dermatopathologic Findings. American Journal of Dermatopathology. 31(6). 532–541. 15 indexed citations
14.
Trefil, Ladislav, et al.. (2009). Ischemia-reperfusion injury in kidney transplantation from non-heart-beating donor--do antioxidants or antiinflammatory drugs play any role?. PubMed. 110(3). 133–6. 7 indexed citations
15.
Hora, Milan, Ondřej Hes, Tomáš Reischig, et al.. (2008). Tumours in End-Stage Kidney. Transplantation Proceedings. 40(10). 3354–3358. 42 indexed citations
16.
Hora, Milan, Tomáš Reischig, Ondřej Hes, Jiří Ferda, & Jiří Klečka. (2006). Urological complications of congenital nephrogenic diabetes insipidus––long-term follow-up of one patient. International Urology and Nephrology. 38(3-4). 531–532. 6 indexed citations
17.
Reischig, Tomáš, Pavel Jindra, J Mareš, et al.. (2005). Valacyclovir for Cytomegalovirus Prophylaxis Reduces the Risk of Acute Renal Allograft Rejection. Transplantation. 79(3). 317–324. 54 indexed citations
18.
Reischig, Tomáš, K Opatrný, Vladislav Třeška, et al.. (2005). Prospective Comparison of Valacyclovir and Oral Ganciclovir for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients. Kidney & Blood Pressure Research. 28(4). 218–225. 19 indexed citations
19.
20.
Opatrný, K, Tomáš Reischig, Jörg Vienken, et al.. (2002). Does Treatment Modality Have an Impact on Anemia in Patients with Chronic Renal Failure? Effect of Low‐ and High‐Flux Biocompatible Dialysis. Artificial Organs. 26(2). 181–188. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raisa Loginov Breakdown of academic impact, for papers by R. Méndez Breakdown of academic impact, for papers by David C. Lowance Breakdown of academic impact, for papers by Mark Harber Breakdown of academic impact, for papers by Marie‐Christine Moal Breakdown of academic impact, for papers by Elizete Keitel Breakdown of academic impact, for papers by Ngoc Thai Breakdown of academic impact, for papers by Miguel S. West Breakdown of academic impact, for papers by Richard Rohrer Breakdown of academic impact, for papers by Jean-Pierre Venetz
Rankless by CCL
2026